Effect of chemotherapy on the survival of patients with generalized plasmacytoma and various hazards of its toxicity
Sakalová, A.; Hrubisko, M.; Gazová, S.; Steruská, M.; Prümmerová, J.; Oravská, D.; Pokorná, G.; Mayer, J.
Vnitrni Lekarstvi 25(5): 425-435
1979
ISSN/ISBN: 0042-773X PMID: 452427 Document Number: 142583
Document emailed within 1 workday
Related Documents
Bucior, J.; Ziółko, E.; Tomczyk, A.; Sosada, K.; Knopik, J.; Kempiński, M. 2004: Effect of palliative chemotherapy with topoisomerase inhibitor on the quality of life and survival of patients with advanced colorectal carcinoma Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 17(101): 457-462Hotta, T.; Takifuji, K.; Arii, K.; Yokoyama, S.; Matsuda, K.; Higashiguchi, T.; Tominaga, T.; Oku, Y.; Yamaue, H. 2006: Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival Anticancer Research 26(2b): 1425-1432
Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Mansvelt, B.; Bertrand, C.; Nockerman, P.; Arnould, P.; Delvaux, P.; Lechien, X.; de Neve de Roden, A. 1997: Study of the toxicity and results of intraperitoneal hyperthermic chemotherapy in 28 patients with peritoneal carcinomatosis Annales de Chirurgie 51(1): 60-67
Logothetis, C.J.; Dexeus, F.H.; Chong, C.; Sella, A.; Ogden, S. 1990: The impact of chemotherapy on the survival of patients with metastatic urothelial tumors Progress in Clinical and Biological Research 350: 107-114
Beatty, P.G.; Kim, B.S.; Rowley, D.A.; Coppleson, L.W. 1976: Antibody against the antigen receptor of a plasmacytoma prolongs survival of mice bearing the tumor Journal of Immunology 116(5): 1391-1396
Costea, I.; Moghrabi, A.; Laverdiere, C.; Graziani, A.; Krajinovic, M. 2006: Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia Haematologica 91(8): 1113-1116
Krasovskiĭ, G.N.; Tolstopiatova, G.V.; Zholdakova, Z.I.; Korkach, V.I.; Bariliak, I.R. 1988: Interlaboratory differences in assessing the toxicity and hazards of trichlorobiphenyl Gigiena i Sanitariia 3: 15-18
Brightwell, R.; Eng, K.; Lele, S. 2017: Use of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patients European Journal of Gynaecological Oncology 38(3): 378-381
Blohmer, J.U.; Paepke, S.; Kissner, L.; Elling, D.; Fleige, B.; Grineisen, Y.; Lichtenegger, W. 1999: Dose- intensified, preoperative and adjuvant chemotherapy in patients with T3- and T4- breast cancer: toxicity, clinical and pathological remission Zentralblatt für Gynakologie 121(11): 522-525
Melichar, B.; Voboril, Z.; Cerman, J.; Melicharová, K.; Mergancová, J.; Voboril, Ré.; Jandík, P. 2006: Survival of patients with colorectal cancer liver metastases treated by regional chemotherapy Hepato-Gastroenterology 53(69): 426-434
Yonemura, Y.; Kinoshita, K.; Fujimura, T.; Fushida, S.; Sawa, T.; Matsuki, N.; Tanaka, S.; Kamata, T.; Takashima, T.; Miyazaki, I. 1996: Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients Hepato-Gastroenterology 43(11): 1260-1272
Li, J.; Zhao, Y.; Luo, S.-K.; Huang, B.-H.; Zhang, G.-C.; Peng, A.-H.; Zheng, D.; Su, C.; Xu, D.-R.; Tong, X.-Z.; Gu, J.-L.; Ding, Y. 2008: The clinical features, chemotherapy responses and survival of 223 patients with newly diagnosed multiple myeloma Zhonghua Yi Xue Za Zhi 88(30): 2140-2143
Korman, D.B.; Maslova, I.A.; Borisov, A.I. 1982: Survival kinetics of breast cancer patients undergoing combined chemotherapy for recurrences and metastases Voprosy Onkologii 28(8): 14-19
Koyama, Y.; Kurita, H.; Koike, T.; Kamata, T.; Nakanishi, Y.; Kobayashi, H. 2014: Retrospective analysis of clinical and pathological factors that influence patient survival in salivary gland cancer - could chemotherapy improve survival ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(2): 199-204
Goerdten, J.; Carrière, I.; Muniz-Terrera, G. 2020: Comparison of Cox proportional hazards regression and generalized Cox regression models applied in dementia risk prediction Alzheimer's and Dementia 6(1): E12041
Othmer, E.; Othmer, S.C. 1987: Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder Journal of Clinical Psychiatry 48(5): 201-203
Voĭtenko, G.A. 1990: The regulation of the composition of commercial forms of pesticides and the principles for evaluating their toxicity and hazards Gigiena i Sanitariia 10: 40-42
Snead, C.; Siegel, N.; Hayslett, J. 1976: Generalized lymphadenopathy and nephrotic syndrome as a manifestation of mephenytoin (mesantoin) toxicity Pediatrics 57(1): 98-101
Tanaka, N.; Matsui, H.; Nagai, Y.; Suzuka, K.; Seki, K.; Sekiya, S. 2002: Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer European Journal of Gynaecological Oncology 23(4): 281-286